Firm Advises on Stryker’s $1.65 Billion Acquisition of Mako Surgical

September 26, 2013

Willkie represents Citigroup Inc., financial adviser to medical device maker Stryker Corporation, in the transaction.

On September 25, it was announced that medical device maker Stryker Corporation agreed to acquire all of the outstanding shares of MAKO Surgical Corp. for $30.00 per share in cash, an aggregate purchase price of approximately $1.65 billion. Willkie represented Citigroup Inc., Stryker's financial adviser, in the transaction.

Based in Kalamazoo, Mich., Stryker is one of the world's leading medical technology companies offering a diverse array of innovative medical technologies including reconstructive implants, medical and surgical equipment, and neurotechnology and spine products. Based in Ft. Lauderdale, Fla., MAKO Surgical markets its RIO® Robotic-Arm Interactive Orthopedic system, joint specific applications for the knee and hip, and proprietary RESTORIS® implants for orthopedic procedures called MAKOplasty®.

The deal was handled by partners Steven Seidman and Laura Delanoy and associate Marit Spekman.